NCT00556686

Brief Summary

The purpose of this study is to examine how compounds produced in patients with canker sores affect wound healing.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2006

Typical duration for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2006

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

November 8, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 12, 2007

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2009

Completed
Last Updated

April 22, 2015

Status Verified

April 1, 2015

Enrollment Period

3.3 years

First QC Date

November 8, 2007

Last Update Submit

April 20, 2015

Conditions

Canker Sore

Study Arms (2)

1

Individuals with a history of canker sores.

2

Individuals with no history of canker sores.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All subjects will be sampled from the community.

You may qualify if:

  • Age 18 or older, both genders
  • History of recurrent aphthous ulcers with 4 or more episodes per year

You may not qualify if:

  • History of salivary gland disease including Sjogren's disease, parotitis, and sialolithiasis
  • History of benign or malignant salivary gland tumor
  • History of celiac disease, ulcerative colitis or Crohn's disease
  • Patients on medications that affect salivary flow such as anti-depressants and anti-cholinergic medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

Biospecimen

Retention: SAMPLES WITHOUT DNA

saliva

MeSH Terms

Conditions

Stomatitis, Aphthous

Condition Hierarchy (Ancestors)

StomatitisMouth DiseasesStomatognathic Diseases

Study Officials

  • Nasim Fazel, MD, DDS

    University of California, Davis

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 8, 2007

First Posted

November 12, 2007

Study Start

August 1, 2006

Primary Completion

December 1, 2009

Study Completion

December 1, 2009

Last Updated

April 22, 2015

Record last verified: 2015-04